Siddharth Chinta

Siddharth Chinta practices at Vidant Medical Center in Greenville, North Carolina.

Siddharth Chinta's NPI, 1184250565, was assigned on March 18, 2020. Siddharth Chinta holds Massachusetts license 1015862.

Siddharth Chinta's primary practice is Vidant Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.

Siddharth Chinta's primary practice is Vidant Medical Center in Greenville, North Carolina. The medical group on file is ECU Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Siddharth Chinta practices. Vendor and product names are available with a free account.

Internal medicine is Siddharth Chinta's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Siddharth Chinta is licensed in Massachusetts.

CMS data shows 401 Medicare services from Siddharth Chinta across 4 procedure codes in 2024, for 124 Medicare patients. Medicare paid $24,317 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 124 Medicare patients who saw Siddharth Chinta in 2024. The largest group is 75 to 84, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Siddharth Chinta's median patient age at 71, with 64% women.

In 2024, Siddharth Chinta wrote 170 Medicare Part D claims for 66 patients. 79% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $8,985 in total drug cost. In 2023, CMS named 29 claims across 1 drug.

Dmand AI links 8 papers to Siddharth Chinta, published from 2020 to 2024. 2023 was the busiest year, with 3. Siddharth Chinta has published most often in Cureus. Siddharth Chinta's most frequent co-authors are Muhammad Adrish, MD, Pradyumna Agasthi, MBBS and Nischit Baral.

CMS Open Payments shows 66 general payments to Siddharth Chinta from 21 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 77% of the total. Abbott Laboratories paid the most, $1,502.